NCT04062357View on ClinicalTrials.gov

Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

January 20, 2019

Study Completion Date

April 20, 2019

Conditions
Lidocaine Spray
Interventions
DRUG

Lidocaine 5% spray

Group 1 (n₌75); was given on demand lidocaine 5% spray for 8 weeks (One to two applications (1-2 ml) of lidocaine 5% sprays; contain 5 -10 mg of lidocaine, in a metered dose aerosol-delivery system).

OTHER

Placebo

Group 2 (n₌75); was given placebo in form on demand alcohol spray for 8 weeks.

Trial Locations (1)

82524

Faculty of Medicine, Sohag University, Egypt, Sohag

All Listed Sponsors
lead

Sohag University

OTHER

NCT04062357 - Effectiveness and Tolerability of Lidocaine 5% Spray in Treatment of Lifelong Premature Ejaculation Patients. | Biotech Hunter | Biotech Hunter